In recent years there have appeared occasional reports of cases of hypothyroidism in which associated findings have been interpreted as evidence of the presence of myxedema heart disease. Fahr5 has pointed out the lack of consideration which has been given to the cardiac features of hypothyroidism in text-books, and until the recent publication of a volume12 devoted to heart disease the space given to this subject was limited. There is no doubt that an advanced grade of hypothyroidism is an uncommon condition and, furthermore, that a striking degree of myxedema heart disease is rare, however, the dangers attendant upon its improper management, and its response to careful therapy make its consideration a matter of importance.
Following the reports of a small number of cases by Zondek"4, by Assman1 and by Meissner9, Fahr' reported six cases which he considered typical of myxedema heart disease. One of his cases was relieved of congestive failure by thyroid extract therapy after rest and digitalis had failed. Other clinicians have been sceptical of the existence of this clinical entity. Willius and Haines"3 reviewed 162 cases of hypothyroidism and were unable to find any instance of cardiovascular disease which they could definitely attribute to myxedema, but only a few of these cases were carefully studied for changes in the cardiac diameters and in the electrocardiagram both before and after thyroid extract therapy. Christian3 reviewed 32 cases and failed to find any with cardiac findings similar to those described by Fahr6, but he emphasized the importance of cautious thyroid extract therapy where cardiac disease might be present. More recently, reports of cases of myxedema heart disease which have been carefully studied have been published by Means For the diagnosis of myxedema heart disease the criteria which were emphasized by Zondek"4 were an enlargement of the heart with a feeble heart action, low amplitude P and T waves in the electrocardiagram, and a decrease in the heart size and an increase in the voltage of the electrocardiagraphic complexes following thyroid extract therapy. Thacher and White10 have reported the electrocardiagraphic changes associated with myxedema. There is absence or inversion of the T waves in Lead II and the P and QRS complexes are usually of low amplitude. The absence or inversion of the T waves in all leads has also been commented upon, and Fahr6 has placed emphasis upon the changes in the T wave in Lead I. In three of the cases reported by Fahr evidence of left ventricular preponderance disappeared after thyroid extract therapy. Since these electrocardiagraphic changes are not limited to cases with associated heart disease and are only corroborative evidence of the presence of that condition, the demonstration of cardiac enlargement would seem essential for diagnosis. In the 22 cases reviewed by Ayman and his collaborators2 an average decrease of 3.3 cm. in cardiac diameter was found following thyroid extract therapy, a minimum decrease of 1.0 cm. and a maximum of 6.3 cm. Means, White and Krantz8 suggest that a lowered tonus of the cardiac muscle may be the cause of the dilatation which disappears after thyroid extract has been given. Although cardiac failure due to myxedema heart disease has been reported, it is certainly not a common finding, and the symptoms and signs of cardiac failure may often be lacking because of the low level of the patient's activity and their absence cannot be relied upon as evidence to exclude heart disease. Two factors which often accompany myxedema and which may affect the size of the heart are obesity and anemia and in considering the decrease in the size of the heart following thyroid extract therapy it is always necessary to keep in mind the possibility that the decrease may have accompanied an improvement in the red blood cell count or a decrease in weight. In summary, the criteria for the diagnosis of myxedema heart disease may be tentatively considered as follows: (1) the presence of hypothyroidism, (2) cardiac enlargement, (3) low amplitude electrocardiagraphic complexes which attain greater voltage following thyroid extract therapy, (4) a decrease in cardiac area following thyroid extract therapy which cannot be ascribed wholly to weight loss or improvement in red blood count, (5) absence of evidence of hypertensive, valvular or coronary heart disease.
Myxedema and arteriosclerosis are frequently associated, and coronary sclerosis may also be present. It is the presence of arteriosclerosis and the possibility of coronary sclerosis which makes the management of these patients a matter of great importance, and it is only logical to institute thyroid extract therapy with care, and to ascertain whether or not cardiac dilatation is present before beginning treatment. Christian3 and White"2 have emphasized the necessity of raising the basal metabolic rate slowly when dilatation or angina pectoris is present in order to avoid suddenly throwing an extra load on the cardiovascular system. The initial dose of thyroid extract given to patients who show evidence of heart disease should be small. It is well to keep these patients in bed during the first few days of the treatment and to start with a dose of one grain daily, which may be gradually increased if the patient does not respond to that amount.
The following case report will serve to illustrate the criteria for the diagnosis of myxedema heart disease and the changes which occur during a course of therapy. It will be seen that marked improvement was obtained with only small doses of thyroid extract.
J. McD. a white carpenter, aged 57, was admitted to the hospital on February 10, 1932. He claimed to have been in good health until August, 1929, when he suffered injuries to his right ankle and right hand which required care for about two months. Since January, 1930, there had been a gradual development of lethargy, dryness of the skin, susceptibility to cold and deepness of voice. Because of an impairment of his general sense of well-being and lack of ambition he did not return to work; although prior to the onset of his symptoms he had always enjoyed his occupation. At no time had the patient noticed either dyspnea or precordial pain and there was no history of attacks of substernal oppression, but of course his activity had been restricted. The past history and the family history were irrelevant.
On physical examination the outstanding feature was the man's appearance: the stolid, expressionless, puffy face, the slow thick speech and the slowness of his movements were striking. The tongue was swollen, there were supraclavicular pads, and the skin was cracked, scaly and dry. The hair on the scalp and at the eyebrows was scanty. The heart was greatly enlarged, and the sounds were of poor quality. The A *-3 FIGURE III. These reductions of orthodiascopic tracings of the cardiac shadow illustrate the marked changes in the cardiac diameters following thyroid extract therapy. The movements of the heart borders on February 1 1, (A) were very sluggish, while those observed on April 2 (B) were of normal excursion.
In Table I certain data concerning the patient's course are recorded. condition. An orthodiascopic examination of the patient's heart before thyroid extract was given showed marked cardiac enlarge-ment and feeble cardiac action. An improvement in all the findings except those observed orthodiascopically might be expected in any case of myxedema following thyroid extract therapy, but it is felt that the decrease in cardiac diameters observed in this case is evidence that myxedema heart disease was present. There was an improvement in the anemia in this case and also a loss of weight, but it is felt that the change in cardiac size is more logically related to decrease in the degree of dilatation of myxedema heart disease present than to either of those factors. It is presumed that the low level of activity of the patient accounts for the absence of symptoms referable to the cardiovascular system. This case report is given in an effort to illustrate the criteria for the diagnosis of this condition and the desirability of obtaining teleroentgenographic studies before beginning thyroid extract therapy. While it is recognized that the acceptance of myxedema heart disease as a clinical entity may not be felt justifiable by all clinicians, the importance of recognizing certain not uncommon cardiovascular changes associated with myxedema is apparent.
